Table 3 Clinical characteristics of children with JIA divided by survivin status
Variables | Survivin-positive (N = 59), Median (IQR) | Survivin-negative (N = 11), Median (IQR) | p value |
|---|---|---|---|
Age [years] | 10 (6.5–15.5) | 11.5 (5.50–17.0) | 0.9227 |
N (%) | N (%) | ||
Sex: girls | 43 (72.88%) | 8 (72.72%) | 1.00 |
Disease duration time [months] | 12 (1.5–36) | 2 (1.5–4) | 0.3721 |
Disease activity | 0 (0–1) | 0 (0–1) | 0.8878 |
ESR [mm/h] | 11 (7–30) | 15 (10–20) | 0.5127 |
CRP [mg/dl] | 1 (0.31–8.93) | 2.02 (0.4–12.2) | 0.6806 |
ANA: positive | 26 (44.07%) | 7 (63.64%) | 0.3272 |
RF: positive | 6 (10.17%) | 3 (27.27%) | 0.1432 |
Anti-CCP (ACPA): positive | 15 (25.42%) | 2 (18.18%) | 0.7215 |